Calcium Carbonate
Brand names: Calcichew, Adcal, Calcichew D3 (with colecalciferol)
Calcium carbonate is a calcium salt used as a calcium supplement, in osteoporosis prophylaxis (often with vitamin D) and as a phosphate binder in chronic kidney disease.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
It provides elemental calcium to support bone mineralisation and, in the gut, binds dietary phosphate to reduce its absorption in renal disease.
Prescribing in practice
- Avoid in hypercalcaemia and severe hypercalciuria, and use with caution where there is a risk of milk-alkali syndrome or renal stones.
- It reduces the absorption of several drugs, including some antibiotics, levothyroxine and bisphosphonates, so doses should be separated.
- As a phosphate binder it is taken with food, whereas as a supplement absorption is best with food and adequate vitamin D.
Monitoring
Monitor serum calcium (and phosphate when used as a binder) particularly in renal impairment.
Counselling the patient
- Separate this medicine in time from thyroid medication, certain antibiotics and bisphosphonates.
- Take with food when used to lower phosphate.
- Report symptoms such as nausea, constipation or confusion that could suggest high calcium.
Evidence & guidelines
Calcium with vitamin D supplementation is recommended by NICE within osteoporosis management for at-risk patients.
Reference: NICE CG146 (Osteoporosis); NICE CG182 (CKD); Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Hyperkalaemia Management Algorithm · Electrolyte Disorders
- FAST Exam Protocol — Focused Assessment with Sonography in Trauma · Trauma
- Corrected Calcium · Electrolytes
- Calcium-Phosphate Product · Electrolytes
- Corrected Calcium (for Albumin) · Electrolytes
- Hyperkalaemia Severity and ECG Risk · Electrolytes
- Diabetic Ketoacidosis (DKA) · JBDS 2013 / Joint British Diabetes Societies; NICE NG17
- Adult Hypoglycaemia (Treated Diabetes) · JBDS-IP (2023): Hospital Management of Hypoglycaemia
- Adrenal Crisis · Society for Endocrinology Emergency Guidance (2024)
- Type 2 Diabetes Management · NICE NG28 2022
- Hyperthyroidism Management · BTA / ETA 2018
- Adrenal Insufficiency · Society of Endocrinology / ESE 2016